Sequential molecular monitoring of chimerism in chronic myeloid leukemia patients receiving donor lymphocyte transfusion for relapse after bone marrow transplantation

Bone Marrow Transplantation

Volumn 19, Issue 7, 1997, Pages 703-707

  Rapanotti, M C ^a   Arcese, W ^a   Buffolino, S ^a   Iori, A P ^a   Mengarelli, A ^a   De Cuia, M R ^a   Cardillo, A ^a   Cimino, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Chimerism; CML relapse; Donor lymphocytes transfusion

Indexed keywords

DNA;

ADULT; ARTICLE; BONE MARROW APLASIA; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CASE REPORT; CHIMERA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOGENETICS; DNA DETERMINATION; FEMALE; GENE FUSION; GENETIC TRANSCRIPTION; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE TRANSFUSION; MALE; METAPHASE; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 0030933515     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700723     Document Type: Article

References (23)

1. Kolb HJ, Mittermuller J, Clemm C et al. Donor leukocyte transfusion for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2466.
2. Bär BMAM, Schattenberg A, Mensink EJBM et al. Donor leukocyte infusion for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation. J Clin Oncol 1993; 11: 513-519.
3. Helg C, Roux E, Beris P et al. Adoptive immunotherapy for recurrent CML after BMT. Bone Marrow Transplant 1993; 12: 125-129.
4. Drobysky WR, Keever CA, Roths MS et al. Salvage immunotherapy using donor leukocyte infusion as treatment for relapsed chronic myelogenous leukemia after bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood 1993; 82: 2310-2318.
5. Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusion in marrow grafted patients. Blood 1995; 86: 2041-2050.
6. Mackinnon S, Barnett S, Heller G, O'Reilly RJ. Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood 1994; 83: 3409-3416.
7. Sparkes MC, Crist ML, Sparkes RS et al. UCLA Transplantation Group. Gene markers in human marrow transplantation. Vox Sang 1977; 33: 202-205.
8. Bär BMAM, Schattenberg A, Van Dijk BA et al. Host and donor erythrocytes repopulation patterns after allogenic bone marrow transplantation analysed with antibody-coated fluorescent microspheres. Br J Haematol 1989; 72: 239-245.
9. De Man AJM, Foolen WJG, Van Dijk BA et al. A fluorescent microsphere method for the investigation of erythrocyte chimerism after allogenic bone marrow transplantation using antigenic differences. Vox Sang 1988; 55: 37-41.
10. Uguzzoli L, Yam P, Petz LD et al. Amplification by the polymerase chain reaction of hypervariable regions of human genome for the evaluation of chimerism after bone marrow transplantation. Blood 1991; 77: 1607-1615.
11. Lawler M, Humphries P, McCann SR. Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction. Blood 1991; 77: 2504-2514.
12. Mackinnon S, Papadopoulos EB, Carabasi MH et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus host-disease. Blood 1995; 86: 1261-1268.
13. Higuchi R. Simple and rapid preparation of sample for PCR. In: Erlich HA (ed). PCR Technology. Principles and Applications for DNA Amplification. Stockton: New York, 1989, p 31.
14. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
15. Sajantila A, Budowle B, Ström M et al. PCR amplification of alleles at D1S80 locus: comparison of a Finnish and North American, Caucasian population sample, and forensic case-work evaluation. Am J Hum Genet 1992; 50: 816-825.
16. Allitto BA, Horn GT, Altherr MR et al. Detection by PCR of the VNTR polymorphism at D4S95. Nucleic Acids Res 1991; 9: 4015.
17. De Corte R, Cuppens H, Marynen P, Cassiman JJ. Rapid detection of hypervariable regions by the polymerase chain reaction technique. DNA Cell Biol 1990; 9: 461-469.
18. Horn GT, Richards B, Klinger KW. Amplification of a highly polymorphic VNTR segment by the polymerase chain reaction. Nucleic Acids Res 1989; 17: 2140.
19. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-chloroform extraction. Anal Biochem 1987; 162: 156-159.
20. Lo Coco F, Mandelli F, Diverio D et al. Therapy-induced Ph́ suppression in chronic myeloid leukemia. Molecular and cytogenetic studies in patients treated with alpha-2b interferon, high dose chemotherapy and autologous stem cell infusion. Bone Marrow Transplant 1990; 6: 253-258.
21. Minn GL, Hibbin J, Arthur C et al. Use of minisatellite DNA probes for recognition and characterization of relapse after allogeneic bone marrow transplantation. Br J Haematol 1988; 68: 195-201.
22. Lawer M, McCann SR, Conneally E, Humphries P. Chimerism following allogeneic bone marrow transplantation: detection of residual host cells using the polymerase chain reaction. Br J Haematol 1989; 73: 205-210.
23. Chalmers EA, Sprul AM, Mills KI et al. Use of the polymerase chain reaction to monitor engraftment following allogeneic bone marrow transplantation. Bone Marrow Transplant 1990; 6: 399-403.